Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL5874528

CCCC[N+](CCCC)(CCCC)CCCC.O=C([O-])C(O)C(O)C(=O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3BCHECHRM1CHRM2CHRM3CHRM4CHRNA3CHRNA4CHRNB2CHRNB4ESR1ESR2GABRA1GABRB1GABRG2GBA1GHSRHRH1HTR1DHTR2AMAOBOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8UGCGrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Tetrabuthylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.46
TSHR P16473 3/20 0.44
CYP3A4 P08684 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
LMNA P02545 1/20 0.44
BLM P54132 1/20 0.44
PMP22 Q01453 1/20 0.44
GPR84 Q9NQS5 3/20 0.42
CA1 P00915 2/20 0.42
FFAR1 O14842 1/20 0.42
SLC22A2 O15244 1/20 0.41
CA2 P00918 1/20 0.40
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
ALOX15 P16050 1/20 0.38
ALOX12 P18054 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HIF1A Q16665 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL5874496 0.94 SLC22A1 (0.52) SLC22A1TSHRCYP3A4GPR84CA1
Tetrabuthylammonium SCHEMBL5874524 0.92 SLC22A1 (0.55) SLC22A1TSHRCYP3A4GPR84FFAR1
Cadaverine Tartrate SCHEMBL15561037 0.91 SLC22A1 (0.45) SLC22A1TSHRCYP3A4TDP1LMNA
Cadaverine Tartrate SCHEMBL9094501 0.90 SLC22A1 (0.52) SLC22A1TSHRCYP3A4GPR84FFAR1
Tetrabuthylammonium SCHEMBL11220045 0.90 SLC22A1 (0.52) SLC22A1TSHRCYP3A4GPR84FFAR1
Tetrapropylammonium SCHEMBL5874101 0.88 TSHR (0.42) SLC22A1TSHRCYP3A4TDP1LMNA
Cadaverine Tartrate SCHEMBL8435543 0.84 DNM1 (0.52) TSHRCYP3A4TDP1LMNABLM
Cetrimonium SCHEMBL5533047 0.84 DNM1 (0.52) TSHRCYP3A4TDP1LMNABLM
Cadaverine Tartrate SCHEMBL8437270 0.84 DNM1 (0.52) TSHRCYP3A4TDP1LMNABLM
Cadaverine Tartrate SCHEMBL15561036 0.82 SLC22A1 (0.52) SLC22A1TSHRCYP3A4GPR84FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119372312-A Biomarker, reagent and kit for early recognition of metastatic lung cancer and application of biomarker 四川省肿瘤医院 2025-01-28 CN claimed
CN-112129938-B Use of UDP-Glc in lung cancer metastasis assessment 中国科学院分子细胞科学卓越创新中心 2023-08-18 CN claimed
CN-112129938-A Application of UDP-Glc in lung cancer metastasis assessment 中国科学院分子细胞科学卓越创新中心 2020-12-25 CN claimed
US-20160141725-A1 Electrolytes and Metal Hydride Batteries BASF CORPORATION 2016-05-19 US claimed
CN-119684381-A Crystalline forms of nicotinamide riboside furanoside salts and nutritional supplements and pharmaceutical compositions containing same 生物合成股份公司 2025-03-25 CN disclosed
CN-119462782-A Method for producing nicotinamide riboside salts, nicotinamide riboside salts per se and use thereof 生物合成股份公司 2025-02-18 CN disclosed
CN-119372312-A Biomarker, reagent and kit for early recognition of metastatic lung cancer and application of biomarker 四川省肿瘤医院 2025-01-28 CN disclosed
CN-117751182-A Method for amplifying human granulocyte-macrophage progenitor cells and application thereof 南加利福尼亚大学 2024-03-22 CN disclosed
CN-112129938-B Use of UDP-Glc in lung cancer metastasis assessment 中国科学院分子细胞科学卓越创新中心 2023-08-18 CN disclosed
US-11485915-B2 Methods of using ionic liquids as corrosion inhibitors BAKER HUGHES HOLDINGS LLC (US) 2022-11-01 US disclosed
CN-112121167-B Application of UDP-Glc in preparing medicine for inhibiting lung cancer metastasis 中国科学院分子细胞科学卓越创新中心 2022-10-11 CN disclosed
CN-107710462-B Electrochemical hydrogen storage electrode and battery 巴斯夫公司 2022-08-02 CN disclosed
US-20160329560-A1 Electrochemical Hydrogen Storage Electrodes and Cells BASF CORPORATION (US) 2016-11-10 US disclosed
US-20160141725-A1 Electrolytes and Metal Hydride Batteries BASF CORPORATION 2016-05-19 US disclosed
US-20160141724-A1 Electrolytes and Metal Hydride Batteries BASF CORPORATION 2016-05-19 US disclosed
US-20160141726-A1 Electrolytes and Metal Hydride Batteries BASF CORPORATION 2016-05-19 US disclosed
US-20160141727-A1 Electrolytes and Metal Hydride Batteries BASF CORPORATION 2016-05-19 US disclosed
US-7128976-B2 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2006-10-31 US disclosed
US-20030091838-A1 Composition for film formation, method of film formation, and silica-based film JSR CORPORATION (JP) 2003-05-15 US disclosed
US-5933693-A Electroconductive elastic member and electrophotographic apparatus using same BRIDGESTONE CORPORATION (JP) 1999-08-03 US disclosed